Cytotoxic Lesion of the Corpus Callosum in an Adolescent with Multisystem Inflammatory Syndrome and SARS-CoV-2 Infection

References

1. 1.↵
   CDC COVID-19 Response Team. Coronavirus disease 2019 in children—United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep 2020;69:422–26 doi:10.15585/mmwr.mm6914e4 pmid:32271728

   CrossRefPubMed
2. 2.↵
   1. Riphagen S,
   2. Gomez X,
   3. Gonzalez-Martinez C, et al

   . Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020;395:1607–08 doi:10.1016/S0140-6736(20)31094-1 pmid:32386565

   CrossRefPubMed
3. 3.↵
   1. Belhadjer Z,
   2. Meot M,
   3. Bajolle F, et al

   . Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation 2020 May 17. [Epub ahead of print] doi:10.1161/CIRCULATIONAHA.120.048360 pmid:32418446

   CrossRefPubMed
4. 4.↵
   1. Licciardi F,
   2. Pruccoli G,
   3. Denina M, et al

   . SARS-CoV-2-induced Kawasaki-like hyperinflammatory syndrome: a novel COVID phenotype in children. Pediatrics 2020 May 21. [Epub ahead of print] doi:10.1542/peds.2020-1711 pmid:32439816

   Abstract/FREE Full Text
5. 5.↵
   1. Dufort EM,
   2. Koumans EH,
   3. Chow Ej, et al

   ; New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team. Multisystem inflammatory syndrome in children in New York State. N Engl J Med 2020;383:347–58 doi:10.1056/NEJMoa2021756 pmid:32598830

   CrossRefPubMed
6. 6.↵
   1. Cheung EW,
   2. Zachariah P,
   3. Gorelik M, et al

   . Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA 2020 June 8. [Epub ahead of print] doi:10.1001/jama.2020.10374 pmid:32511676

   CrossRefPubMed
7. 7.↵
   1. Mao L,
   2. Jin H,
   3. Wang M, et al

   . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683 doi:10.1001/jamaneurol.2020.1127 pmid:32275288

   CrossRefPubMed
8. 8.↵
   1. Dinkin M,
   2. Gao V,
   3. Kahan J, et al

   . COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology 2020 May 1. [Epub ahead of print] doi:10.1212/WNL.0000000000009700 pmid:32358218

   Abstract/FREE Full Text
9. 9.↵
   1. Scullen T,
   2. Keen J,
   3. Mathkour M, et al

   . Coronavirus 2019 (COVID-19)-associated encephalopathies and cerebrovascular disease: the New Orleans Experience. World Neurosurg 2020 May 28. [Epub ahead of print] doi:10.1016/j.wneu.2020.05.192 pmid:32474092

   CrossRefPubMed
10. 10.↵
    1. Hanafi R,
    2. Roger PA,
    3. Perin B, et al

    . COVID-19 neurologic complication with CNS vasculitis-like pattern. AJNR Am J Neuroradiol 2020 June 8. [Epub ahead of print] doi:10.3174/ajnr.A6651 pmid:32554425

    Abstract/FREE Full Text
11. 11.↵
    1. Nicholson P,
    2. Alshafai L,
    3. Krings T

    . Neuroimaging findings in patients with COVID-19. AJNR Am J Neuroradiol 2020 June 11. [Epub ahead of print] doi:10.3174/ajnr.A6630 pmid:32527843

    Abstract/FREE Full Text
12. 12.↵
    1. Takanashi J,
    2. Shirai K,
    3. Sugawara Y, et al

    . Kawasaki disease complicated by mild encephalopathy with a reversible splenial lesion (MERS). J Neurol Sci 2012;315:167–69 doi:10.1016/j.jns.2011.11.022 pmid:22129937

    CrossRefPubMed
13. 13.↵
    1. Starkey J,
    2. Kobayashi N,
    3. Numaguchi Y, et al

    . Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations. Radiographics 2017;37:562–76 doi:10.1148/rg.2017160085 pmid:28165876

    CrossRefPubMed
14. 14.↵
    1. Benameur K,
    2. Agarwal A,
    3. Auld S, et al

    . Encephalopathy and encephalitis associated with cerebrospinal fluid cytokine alterations and coronavirus disease, Atlanta, Georgia, USA. Emerg Infect Dis 2020 June. [Epub ahead of print] doi:10.3201/eid2609.202122 pmid:32487282

    CrossRefPubMed